TP53 and ovarian cancer: Recently, ID8 cells were edited to knock out genes commonly deleted in ovarian cancer, including Trp53, Brca1, and/or Brca2, increasing the preclinical relevance of this model as 96% of HGSC cases have Trp53 mutations and 33% are Brca altered (17–19).